Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Helicobacter

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Helicobacter|March 12, 2002
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID usersDavid Y Graham
Helicobacter|November 28, 2015
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 GenotypeDavid Y Graham
Helicobacter|June 17, 2024
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New EditorDavid Y Graham
Helicobacter|July 1, 2015
Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as AdjuvantsDavid Y Graham
Helicobacter|April 2, 2026
Helicobacter 30 Years On: A Message From the Editor, EmeritusDavid Y Graham
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Helicobacter|May 11, 2006
Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturallyDavid Y Graham, Naomi Uemura
Helicobacter|July 5, 2012
Guide regarding choice of second-line therapy to obtain a high cumulative cure rateDavid Y Graham, Xavier Calvet
Helicobacter|September 20, 2011
Helicobacter pylori therapy demystifiedDavid Y Graham, Maria P Dore
Helicobacter|April 5, 2014
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infectionsTaraq A Attumi, David Y Graham
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Helicobacter|March 12, 2002
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID usersDavid Y Graham
Helicobacter|November 28, 2015
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 GenotypeDavid Y Graham
Helicobacter|June 17, 2024
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New EditorDavid Y Graham
Helicobacter|July 1, 2015
Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as AdjuvantsDavid Y Graham
Helicobacter|April 2, 2026
Helicobacter 30 Years On: A Message From the Editor, EmeritusDavid Y Graham
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Helicobacter|May 11, 2006
Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturallyDavid Y Graham, Naomi Uemura
Helicobacter|July 5, 2012
Guide regarding choice of second-line therapy to obtain a high cumulative cure rateDavid Y Graham, Xavier Calvet
Helicobacter|September 20, 2011
Helicobacter pylori therapy demystifiedDavid Y Graham, Maria P Dore
Helicobacter|April 5, 2014
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infectionsTaraq A Attumi, David Y Graham
Pageof 6